Anthony Farah, MD
Ophthalmology · Williamsburg, VANPI 1659692960
Payments from drug & device makers
Across 123 payments — averaging $67.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Surgical Vision, Inc.$5K
- Alcon$784
- Aerie Pharmaceuticals, Inc.$273
- Ocular Therapeutix, Inc.$261
- Rxsight Inc$205
- AbbVie$193
- plus $1K from 19 others
What the payments were for
- Consulting fees$4,50054%
- Speaking & faculty fees$320%
- Food & beverage$3,79146%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Surgical Vision, Inc. | 23 | $5,287 |
| Alcon | 29 | $784 |
| Aerie Pharmaceuticals, Inc. | 3 | $273 |
| Ocular Therapeutix, Inc. | 2 | $261 |
| Rxsight Inc | 5 | $205 |
| AbbVie(2 entities) | 10 | $193 |
| Glaukos Corporation | 4 | $175 |
| Sun Pharmaceutical Industries Inc. | 9 | $164 |
| Bausch & Lomb Americas Inc. | 8 | $161 |
| Carl Zeiss Meditec, Inc. | 1 | $135 |
| Astellas Pharma US Inc | 1 | $132 |
| Harrow Eye, LLC | 4 | $93 |
| Dompe US, Inc. | 3 | $61 |
| Amgen | 3 | $59 |
| Sight Sciences, Inc. | 3 | $56 |
| Oyster Point Pharma, Inc. | 3 | $55 |
| Tarsus Pharmaceuticals, Inc. | 2 | $54 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 3 | $51 |
| Thea Pharma Inc. | 1 | $24 |
| Apellis Pharmaceuticals, Inc. | 1 | $24 |
| Kala Pharmaceuticals, Inc. | 1 | $20 |
| Abbott | 1 | $15 |
| Rayner Intraocular Lenses Limited | 1 | $15 |
| Oasis Medical, Inc. | 1 | $14 |
| Johnson & Johnson Vision Care, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Catalys Laser System$4,605
- DEXTENZA$261
- Rocklatan$259
- Tecnis IOL$259
- Hydrus Microstent$146
- ARTEVO 800$135
- Izervay$132
- Rhopressa$125
- TECNIS Presbyopia-Correcting IOLs$124
How this compares
$8,323 in reported general payments places this provider in the 85th percentile of 509 ophthalmology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 56 | $73,799 |
| LumiganBimatoprost | 114 | $62,981 |
| RhopressaNetarsudil Mesylate | 46 | $23,997 |
| Cyclosporine | 32 | $23,200 |
| CombiganBrimonidine Tartrate/Timolol | 52 | $18,030 |
| Brimonidine Tartrate | 131 | $8,287 |
| Latanoprost | 808 | $7,934 |
| Prednisolone Acetate | 181 | $7,672 |
| CequaCyclosporine | 11 | $7,517 |
| ProlensaBromfenac Sodium | 20 | $6,896 |
| RocklatanNetarsudil Mesylat/Latanoprost | 19 | $6,755 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 27 | $6,345 |
| Timolol Maleate | 129 | $6,285 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 325 | $4,963 |
| Brinzolamide | 20 | $3,944 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan, Combigan | $193 | $154,810222 claims |
| Aerie Pharmaceuticals, Inc.Rhopressa, Rocklatan | $273 | $30,75265 claims |
| Sun Pharmaceutical Industries Inc.Cequa | $164 | $7,51711 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCProlensa | $51 | $6,89620 claims |
| AlconSimbrinza | $784 | $6,34527 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 509 ophthalmology providers in Virginia.
Other ophthalmology in Williamsburg
- James PaauwLynchburg$7M
- Golnaz JaveyLynchburg$6.7M
- Kapil KapoorNorfolk$4.3M
- Ali TabassianRichmond$2.1M
- Elizabeth Yeu-LinNorfolk$2M
- Ethnie JonesRichmond$2M
- Alan WagnerNorfolk$1.8M
- John SheppardNorfolk$1.2M
- Gustavo CorralesFalls Church$888K
- Frank CotterRoanoke$874K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.